Error: Could not add to watchlist. X

Fennec Pharmaceuticals Inc

+ Watchlist
AHX:CN
Ticker Change
AHX:CN has changed to a new ticker symbol
CAD
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (CAD)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Fennec Pharmaceuticals Inc. is a biotechnology company that develops therapeutic drugs for the treatment of cancer. The Company's lead biotechnology compound works to kill tumor cells (by apoptosis) destroy the blood vessels that feed a cancerous tumor, essentially destroying the tumor's food supply by targeting the cell adhesion molecule N-cadherm.
ADDRESS
68 TW Alexander Drive
Reasearch Triangle Park, NC 27709
United States
PHONE
1-919-636-4530
  • Rostislav Raykov "Rosty"
    Chairman/CEO
  • Krysia Lynes
    Interim CFO
Show More